gamma-aminobutyric acid has been researched along with Endometrial Diseases in 1 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the literature examining the use of gabapentin for treatment of hot flashes during natural or surgically induced menopause." | 8.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "A literature search was conducted via PubMed, MEDLINE, and International Pharmaceutical Abstracts (1948-November 2010) using the search terms gabapentin, hot flashes, and menopause." | 8.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "Studies with data describing gabapentin for hot flash management during natural or surgically induced menopause were included." | 8.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "Gabapentin 600-2400 mg/day in divided doses may be a viable option for treating hot flashes in menopausal women who do not want to use hormone replacement therapy." | 8.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "To review the literature examining the use of gabapentin for treatment of hot flashes during natural or surgically induced menopause." | 4.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "A literature search was conducted via PubMed, MEDLINE, and International Pharmaceutical Abstracts (1948-November 2010) using the search terms gabapentin, hot flashes, and menopause." | 4.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "Studies with data describing gabapentin for hot flash management during natural or surgically induced menopause were included." | 4.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| "Gabapentin 600-2400 mg/day in divided doses may be a viable option for treating hot flashes in menopausal women who do not want to use hormone replacement therapy." | 4.87 | Use of gabapentin for the management of natural or surgical menopausal hot flashes. ( Carroll, DG; Hayes, LP; Kelley, KW, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, LP | 1 |
| Carroll, DG | 1 |
| Kelley, KW | 1 |
1 review available for gamma-aminobutyric acid and Endometrial Diseases
| Article | Year |
|---|---|
Use of gabapentin for the management of natural or surgical menopausal hot flashes.
Topics: Amines; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyri | 2011 |